-+ 0.00%
-+ 0.00%
-+ 0.00%

Hensoldt (XTRA:HAG) Stock Price Tracks Record Orders Against A 92.1x P/E

Simply Wall St·08/01/2026 02:20:21
Listen to the news

Hensoldt heads into this earnings season with a stock that has already run hard, up double digits over the past month and sitting at €79.76 at the last close on 31 July 2026. That backdrop makes today’s sentiment all about one thing: the market is trying to square a premium P/E of 92.1x with an earnings release built around record order momentum and firmer profitability.

The headline is not the latest quarterly earnings per share. It is the combination of record H1 order intake above €2.8b and adjusted EBITDA of €137m with an 11.8% margin that signals the core defense engine is working, while the valuation asks investors to pay up for it.

Is Hensoldt’s 92.1x P/E simply catching up with its order book, or is the stock already pricing in too much future success? See how current multiples compare with intrinsic value in our valuation analysis for Hensoldt

Q2 2026 Earnings Summary

  • Revenue (Q2 2026 vs Q2 2025): €496 million vs. €549 million (revenue declined 9.7%)
  • Net Income, Excl. Extra Items (Q2 2026 vs Q2 2025): loss of €19 million vs. loss of €12 million (loss widened 58.3%)
  • Basic EPS (Q2 2026 vs Q2 2025): loss of €0.16 per share vs. loss of €0.10 per share (loss per share widened 57.4%)
  • Adjusted EBITDA Margin (H1 2026 vs H1 2025): 11.8% vs. 11.3% (margin expanded by 0.5 percentage points)

Prefer clear charts instead of a dense page of earnings figures and order book tables? See Hensoldt’s full visual story, including how its valuation compares with its recent results and order momentum, in the company report for Hensoldt.

XTRA:HAG Trailing 12-Month Earnings & Revenue History as at Aug 2026
XTRA:HAG Trailing 12-Month Earnings & Revenue History as at Aug 2026

Hensoldt’s Bull Story Meets Hard Order And Margin Milestones

Bulls argue Hensoldt is a prime beneficiary of rising defense spending and that careful scaling will turn a record backlog into higher quality growth and better margins. The latest half year goes a long way to support that story. Order intake above €2.8b and a book to bill ratio around 2.4x show that demand and backlog conversion milestones are being hit, not just talked about. Backlog above €10b and record orders in Sensors and Optronics back management’s comments about multiyear procurement cycles.

The bullish narrative also leans on operational leverage. Adjusted EBITDA of €137m with an 11.8% margin and an adjusted EBIT margin of 6.0% both move in the right direction while Hensoldt is still spending on capacity and R&D. That is consistent with a scaling plan that aims for margin improvement while supporting complex programs and international partnerships.

Compare Hensoldt’s margin progress and expanding backlog with where institutional targets actually sit by checking the consensus price target analysis for Hensoldt.

Hensoldt Bear Worries On Execution And Cash Still Bite

Bears argue Hensoldt is heavily exposed to slow procurement cycles, execution hiccups and cash strain if orders do not convert cleanly into revenue and profit. The latest numbers give that view some traction. Q2 revenue fell 9.7% year on year to €496 million, while the loss widened to €19 million and the loss per share deepened to €0.16. That sits awkwardly next to record orders and a backlog above €10b, suggesting conversion remains lumpy.

Concerns about contract risk also find some support. The T126 cancellation only trims around 1% of 2026 revenue, yet it is a live example of how programs can change. Bears also point to funding and ESG pressure. Adjusted free cash flow for H1 stayed negative at €136 million, even if it improved and guidance now targets 50% cash conversion. That still leaves Hensoldt reliant on a strong second half to hit its own milestones.

With adjusted free cash flow still negative and Hensoldt leaning on a stronger second half to back its premium P/E, it makes sense to verify how robust the balance sheet really is. Check the detailed solvency, liquidity, and cash runway breakdown in our financial health analysis of Hensoldt stock.

Stay Ahead With Hensoldt And Simply Wall St

If Hensoldt’s premium P/E, record orders and still negative free cash flow have your attention, register for free with Simply Wall St and add it to a Watchlist to track price against fair value and watch for a more attractive entry point. After you build a position, keep your decisions clear with the Portfolio Command Center that highlights only the key updates on your holdings. For a wider view of what other investors are seeing in Hensoldt and similar stocks, plug into the Community. Spot potential catalysts and risks early so you can act faster and stay ahead of the market.

Seeking Alternatives Beyond Hensoldt?

Fresh stock ideas can move from quiet to flying once the crowd catches on. Use these under the radar for now shortlists before the window narrows and get in early.

  • Spot potential income workhorses with yields that stand out and use the curated 430 dividend fortresses to see which payouts still look supported before prices run away.
  • Track companies where balance sheets support growth and use the hand picked list of solid balance sheet and fundamentals stocks (412 results) while it still highlights quality that the wider market has not fully caught.
  • Target potential growth stories linked to AI infrastructure and review the focused 57 AI infrastructure stocks before any fresh momentum pulls valuations further from your preferred entry range.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.